China Pharma (CPHI) Competitors $2.22 +0.01 (+0.45%) Closing price 05/23/2025 03:59 PM EasternExtended Trading$2.28 +0.06 (+2.70%) As of 05/23/2025 07:02 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesSEC FilingsTrendsBuy This Stock CPHI vs. GBIO, SRZN, CALC, CYCC, DARE, ANVS, EGRX, TENX, GDTC, and TPSTShould you be buying China Pharma stock or one of its competitors? The main competitors of China Pharma include Generation Bio (GBIO), Surrozen (SRZN), CalciMedica (CALC), Cyclacel Pharmaceuticals (CYCC), Daré Bioscience (DARE), Annovis Bio (ANVS), Eagle Pharmaceuticals (EGRX), Tenax Therapeutics (TENX), CytoMed Therapeutics (GDTC), and Tempest Therapeutics (TPST). These companies are all part of the "pharmaceutical products" industry. China Pharma vs. Generation Bio Surrozen CalciMedica Cyclacel Pharmaceuticals Daré Bioscience Annovis Bio Eagle Pharmaceuticals Tenax Therapeutics CytoMed Therapeutics Tempest Therapeutics China Pharma (NYSE:CPHI) and Generation Bio (NASDAQ:GBIO) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, profitability, dividends, valuation, community ranking, media sentiment, analyst recommendations, institutional ownership and risk. Do analysts recommend CPHI or GBIO? Generation Bio has a consensus price target of $7.33, indicating a potential upside of 1,881.45%. Given Generation Bio's stronger consensus rating and higher possible upside, analysts plainly believe Generation Bio is more favorable than China Pharma.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score China Pharma 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Generation Bio 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the media prefer CPHI or GBIO? In the previous week, China Pharma had 2 more articles in the media than Generation Bio. MarketBeat recorded 2 mentions for China Pharma and 0 mentions for Generation Bio. Generation Bio's average media sentiment score of 0.00 beat China Pharma's score of -0.35 indicating that Generation Bio is being referred to more favorably in the news media. Company Overall Sentiment China Pharma Neutral Generation Bio Neutral Do insiders and institutionals have more ownership in CPHI or GBIO? 95.2% of Generation Bio shares are held by institutional investors. 17.3% of China Pharma shares are held by insiders. Comparatively, 21.8% of Generation Bio shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Which has better valuation & earnings, CPHI or GBIO? China Pharma has higher earnings, but lower revenue than Generation Bio. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioChina Pharma$4.53M1.60-$3.08MN/AN/AGeneration Bio$24.56M1.01-$126.61M-$1.08-0.34 Which has more volatility and risk, CPHI or GBIO? China Pharma has a beta of 0.85, indicating that its stock price is 15% less volatile than the S&P 500. Comparatively, Generation Bio has a beta of 2.76, indicating that its stock price is 176% more volatile than the S&P 500. Does the MarketBeat Community believe in CPHI or GBIO? Generation Bio received 48 more outperform votes than China Pharma when rated by MarketBeat users. Likewise, 72.73% of users gave Generation Bio an outperform vote while only 0.00% of users gave China Pharma an outperform vote. CompanyUnderperformOutperformChina PharmaOutperform VotesNo VotesUnderperform Votes94100.00% Generation BioOutperform Votes4872.73% Underperform Votes1827.27% Is CPHI or GBIO more profitable? China Pharma has a net margin of -85.56% compared to Generation Bio's net margin of -782.86%. China Pharma's return on equity of -63.93% beat Generation Bio's return on equity.Company Net Margins Return on Equity Return on Assets China Pharma-85.56% -63.93% -31.42% Generation Bio -782.86%-104.85%-49.54% SummaryGeneration Bio beats China Pharma on 10 of the 16 factors compared between the two stocks. Get China Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for CPHI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CPHI vs. The Competition Export to ExcelMetricChina PharmaPharmaceutical IndustryMedical SectorNYSE ExchangeMarket Cap$7.24M$6.46B$5.34B$19.28BDividend YieldN/A2.63%5.27%3.85%P/E RatioN/A8.4426.9634.43Price / Sales1.60258.98399.0834.86Price / CashN/A65.8538.3217.51Price / Book3.176.416.774.69Net Income-$3.08M$143.95M$3.24B$1.02B7 Day PerformanceN/A0.24%0.26%-2.38%1 Month Performance34.55%0.09%6.07%4.34%1 Year Performance-92.47%0.20%18.46%4.87% China Pharma Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CPHIChina PharmaN/A$2.22+0.5%N/A-92.6%$7.24M$4.53M0.00250News CoverageAnalyst UpgradeGBIOGeneration Bio3.6718 of 5 stars$0.40+5.4%$7.33+1,725.1%-88.2%$26.94M$24.56M-0.18150Gap UpSRZNSurrozen2.9342 of 5 stars$8.03+13.1%$38.50+379.5%-22.6%$26.35M$10.66M-0.3280Gap DownCALCCalciMedica1.9902 of 5 stars$1.86-7.0%$18.00+867.7%-66.0%$25.99MN/A-1.7230CYCCCyclacel Pharmaceuticals0.3045 of 5 stars$2.00flatN/A-95.6%$25.92M$43,000.00-0.2114Upcoming EarningsDAREDaré Bioscience1.3863 of 5 stars$2.92+1.0%$12.00+311.0%-46.8%$25.84M$9,784.00-4.9430ANVSAnnovis Bio1.3011 of 5 stars$2.11+17.9%$34.75+1,546.9%-71.9%$25.48MN/A-0.473Gap DownEGRXEagle PharmaceuticalsN/A$1.94flatN/A-46.4%$25.20M$257.55M0.00100Gap UpTENXTenax Therapeutics1.8722 of 5 stars$6.02+2.2%$17.50+190.7%+70.4%$24.97MN/A-2.439GDTCCytoMed Therapeutics1.6976 of 5 stars$2.25-3.4%$5.00+122.2%+9.2%$24.62M$69,501.000.00N/AGap UpTPSTTempest Therapeutics1.9677 of 5 stars$6.66-2.8%$30.00+350.5%-85.1%$24.52MN/A-4.3520Gap Down Related Companies and Tools Related Companies Generation Bio Competitors Surrozen Competitors CalciMedica Competitors Cyclacel Pharmaceuticals Competitors Daré Bioscience Competitors Annovis Bio Competitors Eagle Pharmaceuticals Competitors Tenax Therapeutics Competitors CytoMed Therapeutics Competitors Tempest Therapeutics Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:CPHI) was last updated on 5/24/2025 by MarketBeat.com Staff From Our PartnersTrump Predicts Dollar DownfallREAD THIS VERY CAREFULLY: If you have $100,000 or more saved for retirement, this may make you VERY angry... ...Augusta Precious Metals | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored$19 for a FULL YEAR of stock picks?!Invest in Musk's AI Play With Just $100 You don't need deep pockets to ride the next wave of AI wealth. ...Behind the Markets | SponsoredTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredAfter Monday, price goes up 600% (hurry)Right now, for a limited time… You can get up to 52 Money Monday trades for just $7! Thanks to Wall Street’...Timothy Sykes | SponsoredMemorial Day Sale! Save 85% on Weiss Crypto Investor!President Trump just made his first big crypto move … Announcing the creation of a national strategic reser...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding China Pharma Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share China Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
